Publications
CER Interview with Dr. Maureen Maguire
| Type: | Podcast |
| Date: | December 12, 2011 |
| Related Topics: | Aging Research, Drug Development, Drug Safety, Medical Innovation, Policy, Research, Vision Loss |
Maureen G. Maguire, PhD, received her doctoral degree from the Department of Biostatistics, Johns Hopkins Bloomberg School Public Health and then joined the faculty of the Department of Ophthalmology, School of Medicine, Johns Hopkins University. Dr. Maguire served in increasingly more responsible positions (protocol monitor, biostatistician, senior biostatistician, deputy director, director) in as series of multicenter clinical trains in ophthalmology that were based either in the School of Medicine or School of Public Health. During this period, she also collaborated on multiple clinical research projects with colleagues in the Department of Ophthalmology and in teaching research methods with colleagues in the Welch Center for Prevention, a joint venture of the Schools of Medicine and Public Health.
In July 1994, Dr. Maguire joined the faculty of the University of Pennsylvania to establish the Center for Preventive Ophthalmology and Biostatistics (CPOB). Since then, she has held leadership positions in several multicenter clinical trials for the prevention and treatment of age-related macular degeneration sponsored by industry and the NIH, including the ongoing CATT trial. In addition, she was actively involved in the development of the Vision In Preschoolers Study, an NEI-sponsored, multicenter, clinical investigation of methods for screening young children for vision problems.
Dr. Maguire is now the Carolyn F. Jones Professor of Ophthalmology and Vice Chair for Clinical Research in the Department of Ophthalmology. She has served on and chaired several data and safety monitoring committees and is on the editorial board of the journal Ophthalmology and Cornea. She has more than 125 publications in the areas of ophthalmology and clinical research.
Tweet
In July 1994, Dr. Maguire joined the faculty of the University of Pennsylvania to establish the Center for Preventive Ophthalmology and Biostatistics (CPOB). Since then, she has held leadership positions in several multicenter clinical trials for the prevention and treatment of age-related macular degeneration sponsored by industry and the NIH, including the ongoing CATT trial. In addition, she was actively involved in the development of the Vision In Preschoolers Study, an NEI-sponsored, multicenter, clinical investigation of methods for screening young children for vision problems.
Dr. Maguire is now the Carolyn F. Jones Professor of Ophthalmology and Vice Chair for Clinical Research in the Department of Ophthalmology. She has served on and chaired several data and safety monitoring committees and is on the editorial board of the journal Ophthalmology and Cornea. She has more than 125 publications in the areas of ophthalmology and clinical research.
"I think patients and the public need to weigh the differential costs of the drug, with the safety profile, with the number of injections that are required, and think about which treatment approach is best for them. And what might be best for the public funders of healthcare."
Tweet
This podcast series provides expert reactions to the CATT trial data in terms of what it will mean for wAMD patients and professionals, and its potential impact on future trials, policies and innovation.
To listen to interviews on this topic with other experts, click here.
To listen to interviews on this topic with other experts, click here.
Living Longer and Loving It!
Sign up for the Alliance's quarterly newsletter and get timely information on advancements in science, treatment, and health policy that help you "Live Longer and Love It."